GEHC Insider Filing: CFO RSU Withholding of 3,238 Shares at $73.73

Rhea-AI Filing Summary

James Saccaro, Chief Financial Officer of GE HealthCare Technologies Inc. (GEHC), reported disposals on 09/01/2025. The Form 4 shows two dispositions coded F (withholding of shares to satisfy tax obligations) tied to the vesting of restricted stock units. The transactions show 1,740 shares disposed at $73.73 and 1,498 shares disposed at $73.73. Following the reported transactions, the filings list beneficial ownership amounts of 60,092 shares and 58,594 shares respectively. The Form 4 was submitted by an attorney-in-fact and identifies the transaction as tax withholding related to RSU vesting.

Insights

Financial Analyst

TL;DR: Routine tax-withholding dispositions by the CFO on RSU vesting; informational, not materially market-moving.

The report documents two small disposals totaling 3,238 shares via withholding to satisfy tax obligations at a price of $73.73 per share on 09/01/2025. Such transactions are standard when restricted stock units vest and do not represent open-market selling pressure by the executive. The remaining beneficial ownership figures are disclosed for completeness. There is no indication of additional compensatory or unusual arrangements in the filing.

Corporate Governance Expert

TL;DR: Disclosure aligns with Section 16 reporting; transaction coded correctly as tax withholding on RSU vesting.

The Form 4 identifies the reporting person as the CFO and uses transaction code F, consistent with share withholding to cover tax liabilities on vested equity. The filing includes required post-transaction beneficial ownership counts and was signed by an authorized attorney-in-fact. From a governance and compliance perspective, the submission appears routine and complete based on the information provided.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider SACCARO JAMES

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.01 per share	1,740	$73.73	$128K
Tax Withholding	Common Stock, par value $0.01 per share	1,498	$73.73	$110K

Holdings After Transaction: Common Stock, par value $0.01 per share — 60,092 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SACCARO JAMES

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/01/2025		F		1,740(1)	D	$73.73	60,092	D
Common Stock, par value $0.01 per share	09/01/2025		F		1,498(1)	D	$73.73	58,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.